Developer docs
API playgroundTry for free, no card

Search company profiles

ENTRELAC.COOP

Full company profile

uuid02lylzi

Namestring
ENTRELAC.COOP
Legal namestring
ENTRELAC.COOP
Websiteurl
entrelac.coop
Company typeenum
Private
Founded yearint
2022
Descriptiontext

Entrelac.coop is a French cooperative company (Société Coopérative d'Intérêt Collectif, SCIC) founded in 2022 and headquartered in Bordeaux, positioning itself as the first cooperative in Europe dedicated to innovation in male contraception. Its primary mission is to support project leaders in the certification and market launch of male contraception medical devices, with the flagship project being the Thermal Male Contraception Ring (Anneau de Contraception Masculine Thermique) — a reversible heat-based device targeting effectiveness comparable to vasectomy or hormonal implants, with planned availability in European pharmacies by 2028. The company also publishes a Practical Guide to Thermal Contraception, which won the UNESCO Chair Sexual Health & Human Rights First Innovation Prize in 2023.

The core technology is a non-hormonal, heat-based contraceptive ring worn by the user; effectiveness claims rest on three-month spermogram data from named user testimonials rather than published clinical trial endpoints in the disclosed sources. The business model is community-driven rather than venture-backed: members purchase social shares at a fixed 50€ per share (with no market fluctuation and an 18% Madelin-law tax deduction through end-2023), supplemented by one-time and recurring donations. Distribution is entirely direct-to-individual via the societaire.entrelac.coop portal, and the company discloses 0 sociétaires and 52% achievement of its funding target at the most recent scrape.

Strategic positioning is supported by a small set of recognitions — the 2022 Male Contraception Initiative Development Award for clinical trial funding, the 2023 UNESCO Innovation Prize, and a 2023 Région Nouvelle-Aquitaine cooperative-creation grant — and by earned media placements across France Info, Médiapart, France 5, Envoyé Spécial, and Neon Magazine. There is no institutional venture capital, no M&A activity, no patents disclosed, no AI/ML capability disclosed, and the management team is led by Antoine Kolodziej as Director of Publication, with the only formal external partnership being a visual-identity engagement with Horizon Chromatique.

Short descriptiontext

Entrelac.coop is a French cooperative (SCIC) founded in 2022 in Bordeaux that incubates and funds the certification of male contraception medical devices, led by its flagship thermal contraception ring project targeting European pharmacy availability by 2028.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBordeaux, France
HQ citystring
Bordeaux
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
male contraception devices, thermal contraceptive ring, reproductive health innovation, medical device certification, cooperative membership
Industry1 code
PRIMARYCRADAMAH
Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
Product category
Male Contraception Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Social Shares (Parts Sociales)
TypeSubscription Recurring
Description

Members purchase social shares at 50€ each to become cooperative shareholders and support the company's operations and product development.

entrelac.coop
2Donations
TypeSubscription Recurring
Description

One-time and recurring donations to support the cooperative's mission, including monthly recurring donations and one-time contributions.

entrelac.coop
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Social Share - 50€ per share
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Single share = 50€. No market fluctuations. 18% tax deduction available for individual investors under Madelin law.

entrelac.coop
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Entrelac.coop is a cooperative incubator supporting the development and medical-device certification of a reversible thermal male contraception ring (anneau thermique) that uses heat to provide effective, reversible male contraception comparable to vasectomy. The cooperative also produces and distributes a practical guide to thermal contraception as an educational resource. The product is targeted for European pharmacy availability by 2028.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Effectiveness comparable to vasectomy or implant according to 3-month spermogram results
+1 more record
Product overview1 text field

Entrelac.coop is a cooperative company dedicated to innovation in male contraception. Their primary product is the Thermal Male Contraception Ring (Anneau de Contraception Masculine Thermique), a reversible heat-based male contraceptive device currently undergoing medical device certification with planned availability in European pharmacies by 2028. They also offer a Practical Guide to Thermal Contraception, which serves as an educational resource supporting the ring's use. The cooperative supports project leaders in certification and market launch of male contraception products.

Product and service2 records
1Anneau de Contraception Masculine Thermique (Thermal Male Contraception Ring)
CategoryMale Contraception Medical Device
Description

A reversible thermal male contraception ring designed to provide effective male contraception through heat-based technology, targeting effectiveness comparable to vasectomy. Currently under development for medical device certification with planned availability in European pharmacies by 2028. Intended for men seeking reversible contraception alternatives to condoms or female contraceptive methods.

2Guide Pratique de Contraception Thermique (Practical Guide to Thermal Contraception)
CategoryEducational Resource
Description

A free practical guide to thermal male contraception featuring checklists for starting, a bullet journal for daily tracking, a FAQ based on user experience, and a summary of the contraceptive protocol. Distributed as a free downloadable resource supporting use of the thermal ring.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Horizon Chromatique
Strategic tierMinorTypeOthers
Description

Visual identity design partner responsible for creating Entrelac.coop's brand visual identity.

entrelac.coop
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers8 records
1Male Contraception Initiative
TypeEmerging player
Description

Non-profit funder of male contraception research that awarded Entrelac its 2022 Development Award. Directly comparable as a stakeholder in the male contraception ecosystem focused on advancing non-hormonal, reversible male contraceptive methods.

TypeEmerging player
Description

International non-profit research organization that has historically led development of contraceptive technologies, including male methods like hormonal gels. Comparable as an R&D-driven reproductive health innovator with mission alignment to Entrelac's equitable contraception focus.

TypeDirect peer
Description

US-based biotech developing a non-hormonal, reversible male contraceptive targeting sperm motility via EPPIN protein. Direct peer pursuing a similar goal - reversible, non-hormonal male contraception - with a different mechanism.

4Callaly
TypeEmerging player
Description

UK-based reproductive health company offering sustainable period care and reproductive health products. Comparable as a European consumer health brand focused on reproductive health innovation with values-aligned positioning.

TypeEmerging player
Description

Medical device startup developing a reversible vas deferens valve for male contraception. Direct peer in the male contraceptive device space with overlapping target market and regulatory pathway.

TypeDirect peer
Description

US-based medical device company developing a reversible vas deferens occlusion device (Plan A) for male contraception. Direct competitor pursuing the same goal - reversible, non-hormonal male contraception - via a different mechanism.

TypeDirect peer
Description

Developer of Plan A, a reversible vas deferens occlusion device for male contraception. Direct peer competing for the same target market with significant venture backing.

TypeDirect peer
Description

Biotech company developing a hormonal male contraceptive pill (YCT-529). Direct competitor in the male contraception space with a different technical approach but addressing the same unmet need.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

ENTRELAC.COOP

Male Contraception Medical Devicesentrelac.coop

Entrelac.coop is a French cooperative (SCIC) founded in 2022 in Bordeaux that incubates and funds the certification of male contraception medical devices, led by its flagship thermal contraception ring project targeting European pharmacy availability by 2028.

What ENTRELAC.COOP does

Entrelac.coop is a French cooperative company (Société Coopérative d'Intérêt Collectif, SCIC) founded in 2022 and headquartered in Bordeaux, positioning itself as the first cooperative in Europe dedicated to innovation in male contraception. Its primary mission is to support project leaders in the certification and market launch of male contraception medical devices, with the flagship project being the Thermal Male Contraception Ring (Anneau de Contraception Masculine Thermique) — a reversible heat-based device targeting effectiveness comparable to vasectomy or hormonal implants, with planned availability in European pharmacies by 2028. The company also publishes a Practical Guide to Thermal Contraception, which won the UNESCO Chair Sexual Health & Human Rights First Innovation Prize in 2023.

The core technology is a non-hormonal, heat-based contraceptive ring worn by the user; effectiveness claims rest on three-month spermogram data from named user testimonials rather than published clinical trial endpoints in the disclosed sources. The business model is community-driven rather than venture-backed: members purchase social shares at a fixed 50€ per share (with no market fluctuation and an 18% Madelin-law tax deduction through end-2023), supplemented by one-time and recurring donations. Distribution is entirely direct-to-individual via the societaire.entrelac.coop portal, and the company discloses 0 sociétaires and 52% achievement of its funding target at the most recent scrape.

Strategic positioning is supported by a small set of recognitions — the 2022 Male Contraception Initiative Development Award for clinical trial funding, the 2023 UNESCO Innovation Prize, and a 2023 Région Nouvelle-Aquitaine cooperative-creation grant — and by earned media placements across France Info, Médiapart, France 5, Envoyé Spécial, and Neon Magazine. There is no institutional venture capital, no M&A activity, no patents disclosed, no AI/ML capability disclosed, and the management team is led by Antoine Kolodziej as Director of Publication, with the only formal external partnership being a visual-identity engagement with Horizon Chromatique.

ENTRELAC.COOP firmographics

Firmographics
Name
ENTRELAC.COOP
Legal name
ENTRELAC.COOP
Website
https://entrelac.coop
Company type
Private
Founded year
2022
Operating status
Operating
Headcount range
1–10 employees
Short description
Entrelac.coop is a French cooperative (SCIC) founded in 2022 in Bordeaux that incubates and funds the certification of male contraception medical devices, led by its flagship thermal contraception ring project targeting European pharmacy availability by 2028.
Ownership category
akta.pro rank

ENTRELAC.COOP industry classification

Industry
Product category
Male Contraception Medical Devices
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
akta.pro industry
PRIMARYCRADAMAH
Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests)
Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

  • Male contraception devices
  • Thermal contraceptive ring
  • Reproductive health innovation
  • Medical device certification
  • Cooperative membership

Where ENTRELAC.COOP is headquartered

Location

Headquarters

HQ city
Bordeaux
HQ country
France
HQ region
Europe

Offices1 record

Markets served

ENTRELAC.COOP business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Social Shares (Parts Sociales): Members purchase social shares at 50€ each to become cooperative shareholders and support the company's operations and product development.
  2. Donations: One-time and recurring donations to support the cooperative's mission, including monthly recurring donations and one-time contributions.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractSocial Share - 50€ per share

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

ENTRELAC.COOP product offering

Product offering

Core offering

Entrelac.coop is a cooperative incubator supporting the development and medical-device certification of a reversible thermal male contraception ring (anneau thermique) that uses heat to provide effective, reversible male contraception comparable to vasectomy. The cooperative also produces and distributes a practical guide to thermal contraception as an educational resource. The product is targeted for European pharmacy availability by 2028.

Product overview

Entrelac.coop is a cooperative company dedicated to innovation in male contraception. Their primary product is the Thermal Male Contraception Ring (Anneau de Contraception Masculine Thermique), a reversible heat-based male contraceptive device currently undergoing medical device certification with planned availability in European pharmacies by 2028. They also offer a Practical Guide to Thermal Contraception, which serves as an educational resource supporting the ring's use. The cooperative supports project leaders in certification and market launch of male contraception products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Anneau de Contraception Masculine Thermique (Thermal Male Contraception Ring) A reversible thermal male contraception ring designed to provide effective male contraception through heat-based technology, targeting effectiveness comparable to vasectomy. Currently under development for medical device certification with planned availability in European pharmacies by 2028. Intended for men seeking reversible contraception alternatives to condoms or female contraceptive methods.
  • Guide Pratique de Contraception Thermique (Practical Guide to Thermal Contraception) A free practical guide to thermal male contraception featuring checklists for starting, a bullet journal for daily tracking, a FAQ based on user experience, and a summary of the contraceptive protocol. Distributed as a free downloadable resource supporting use of the thermal ring.

Quantifiable outcome

  • Effectiveness comparable to vasectomy or implant according to 3-month spermogram results
  • +1 more outcomes

Companies that use ENTRELAC.COOP

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

ENTRELAC.COOP technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

ENTRELAC.COOP partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Horizon ChromatiqueminorOthersVisual identity design partner responsible for creating Entrelac.coop's brand visual identity.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

ENTRELAC.COOP competitors and assessment

Company assessment

Emerging players

  • Male Contraception Initiative: Non-profit funder of male contraception research that awarded Entrelac its 2022 Development Award. Directly comparable as a stakeholder in the male contraception ecosystem focused on advancing non-hormonal, reversible male contraceptive methods.
  • Population Council: International non-profit research organization that has historically led development of contraceptive technologies, including male methods like hormonal gels. Comparable as an R&D-driven reproductive health innovator with mission alignment to Entrelac's equitable contraception focus.
  • Callaly: UK-based reproductive health company offering sustainable period care and reproductive health products. Comparable as a European consumer health brand focused on reproductive health innovation with values-aligned positioning.
  • Revolution Contraceptives: Medical device startup developing a reversible vas deferens valve for male contraception. Direct peer in the male contraceptive device space with overlapping target market and regulatory pathway.

Direct peers

  • Eppin Pharma: US-based biotech developing a non-hormonal, reversible male contraceptive targeting sperm motility via EPPIN protein. Direct peer pursuing a similar goal - reversible, non-hormonal male contraception - with a different mechanism.
  • Contraline: US-based medical device company developing a reversible vas deferens occlusion device (Plan A) for male contraception. Direct competitor pursuing the same goal - reversible, non-hormonal male contraception - via a different mechanism.
  • NEXT Life Sciences: Developer of Plan A, a reversible vas deferens occlusion device for male contraception. Direct peer competing for the same target market with significant venture backing.
  • YourChoice Therapeutics: Biotech company developing a hormonal male contraceptive pill (YCT-529). Direct competitor in the male contraception space with a different technical approach but addressing the same unmet need.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

ENTRELAC.COOP social profiles

Digital presence

ENTRELAC.COOP compliance and trust

Trust signal

Compliance3 records

ENTRELAC.COOP financial estimates

Financial estimate

Revenue estimate

Valuation estimate

ENTRELAC.COOP leadership team

Management profile

Number of profiles

Profiles1 record

ENTRELAC.COOP funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

ENTRELAC.COOP M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ENTRELAC.COOP

What does ENTRELAC.COOP do?

Entrelac.coop is a cooperative incubator supporting the development and medical-device certification of a reversible thermal male contraception ring (anneau thermique) that uses heat to provide effective, reversible male contraception comparable to vasectomy. The cooperative also produces and distributes a practical guide to thermal contraception as an educational resource. The product is targeted for European pharmacy availability by 2028.

Is ENTRELAC.COOP a public or private company?

ENTRELAC.COOP is a private company. It is classified as management employee owned and is currently operating.

When was ENTRELAC.COOP founded?

ENTRELAC.COOP was founded in 2022. It employs 1 to 10 people.

Where is ENTRELAC.COOP based?

ENTRELAC.COOP is headquartered in Bordeaux, France, in the Europe region.

How does ENTRELAC.COOP make money?

Two revenue lines are on record. Social Shares (Parts Sociales) is the primary driver. The others are donations.

Who are ENTRELAC.COOP's main competitors?

Emerging players on record are Male Contraception Initiative, Population Council, Callaly and Revolution Contraceptives. Direct peers are Eppin Pharma, Contraline, NEXT Life Sciences and YourChoice Therapeutics.

Does ENTRELAC.COOP have an API?

No public API is recorded for ENTRELAC.COOP.

What industry is ENTRELAC.COOP in?

ENTRELAC.COOP's product category is Male Contraception Medical Devices. Its primary akta.pro industry code is CRADAMAH, Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests). Its NAICS code is 339113.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales